Lalande Kevin M. is a director of Lumos Pharma Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Molecular Templates, Inc.
4 Apr 24
4
Molecular Templates, Inc.
31 Oct 23
4
LUMOS PHARMA, INC.
12 May 23
4
Molecular Templates, Inc.
21 Jun 22
4
Molecular Templates, Inc.
6 Jun 22
4
LUMOS PHARMA, INC.
9 May 22
4
LUMOS PHARMA, INC.
10 Sep 21
4
LUMOS PHARMA, INC.
7 Sep 21
4
LUMOS PHARMA, INC.
1 Sep 21
4
LUMOS PHARMA, INC.
27 Aug 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
2 Apr 24 | MTEM Molecular Templates | Common Stock | Grant | Acquire A | Yes | No | 2.35 | 175,000 | 411.25 k | 175,000 |
2 Apr 24 | MTEM Molecular Templates | Warrants Common Stock | Grant | Acquire A | Yes | No | 0.125 | 1,154,154 | 144.27 k | 1,154,154 |
2 Apr 24 | MTEM Molecular Templates | Pre-Funded Warrants Common Stock | Grant | Acquire A | Yes | No | 2.349 | 402,077 | 944.48 k | 402,077 |
27 Oct 23 | MTEM Molecular Templates | Stock Option Common Stock | Grant | Acquire A | No | No | 6.06 | 1,000 | 6.06 k | 1,000 |
10 May 23 | LUMO Lumos Pharma | Stock Option Common Stock | Grant | Acquire A | No | No | 3.42 | 3,345 | 11.44 k | 3,345 |